Header Logo

Connection

MICHAEL E RYTTING to Aminoglycosides

Back to Details
This is a "connection" page, showing publications MICHAEL E RYTTING has written about Aminoglycosides.
MICHAEL E RYTTING
Connection Strength
0.060
Aminoglycosides
  1. Acute myeloid leukaemia. Lancet. 2018 08 18; 392(10147):593-606.
    View in: PubMed
    Score: 0.036
  2. Inotuzumab ozogamicin, an anti-CD22-calecheamicin conjugate, for refractory and relapsed acute lymphocytic leukaemia: a phase 2 study. Lancet Oncol. 2012 Apr; 13(4):403-11.
    View in: PubMed
    Score: 0.023
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.